This Daktronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga·06/11 11:17
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Piper Sandler analyst David Westenberg initiated coverage on Thermo Fisher Scientific Inc (NYSE:TMO) with a Neutral rating and announced a price target of $510. Thermo Fisher shares closed at $482.04 on Wednesday. See how other analysts view this stock.
Roth Capital analyst Thomas Hayes initiated coverage on Daktronics Inc(NASDAQ:DAKT) with a Buy rating and announced a price target of $26. Daktronics shares closed at $19.13 on Wednesday. See how other analysts view this stock.
BTIG analyst Andre Madrid initiated coverage on Voyager Technologies Inc(NYSE:VOYG) with a Buy rating and announced a price target of $55. Voyager Technologies shares closed at $41.28 on Wednesday. See how other analysts view this stock.
Piper Sandler analyst David Westenberg initiated coverage on Danaher Corp(NYSE:DHR) with a Neutral rating and announced a price target of $200. Danaher shares closed at $183.63 on Wednesday. See how other analysts view this stock.
BTIG analyst Jeet Mukherjee initiated coverage on Sensei Biotherapeutics Inc(NASDAQ:SNSE) with a Buy rating and announced a price target of $55. Sensei Biotherapeutics shares closed at $11.41 on Wednesday. See how other analysts view this stock.
Considering buying DAKT stock? Here’s what analysts think:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.